Albert David Limited board meeting intimation for Q4FY26 under Regulation 29 scheduled on May 12, 2026

1 min read     Updated on 04 May 2026, 07:25 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Albert David Limited has informed the stock exchanges that a meeting of its Board of Directors is scheduled to be held on May 12, 2026, under Regulation 29 of SEBI Listing Regulations. The board will consider and approve the audited financial results for the fourth quarter and financial year ended March 31, 2026, and discuss the recommendation of final dividend for the financial year ended March 31, 2026. The trading window for dealing in equity shares of the company has been closed from April 1, 2026, and will open 48 hours after the declaration of the results.

powered bylight_fuzz_icon
39448525

*this image is generated using AI for illustrative purposes only.

Albert David Limited has intimated the stock exchanges about a scheduled meeting of its Board of Directors to be held on Tuesday, May 12, 2026. The meeting has been convened in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Agenda for Board Meeting

The Board of Directors will consider the following key matters during the meeting:

  • Consider, approve and take on record the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended on March 31, 2026
  • Consider recommendation of Final Dividend, if any, for the Financial Year ended on March 31, 2026

Trading Window Closure

The company has announced that the trading window for dealing in equity shares of the company is currently closed. The window was closed from April 1, 2026, and shall reopen 48 hours after the declaration of the financial results.

Key Details

Particulars Details
Board Meeting Date May 12, 2026
Financial Period Q4 and FY ended March 31, 2026
Trading Window Closure April 1, 2026
Trading Window Reopening 48 hours post-results declaration
Scrip Code (BSE) 524075
Symbol (NSE) ALBERTDAVD

The notice has been addressed to the General Manager of the Department of Corporate Services at BSE Limited and the Manager - Listing Department at the National Stock Exchange of India Limited. The intimation was signed by Lalit Lohia, Company Secretary & Compliance Officer, on May 4, 2026. The notice is also available on the company's official website at www.albertdavidindia.com .

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
-2.07%+9.91%+19.82%-9.33%-3.09%+76.28%

How does Albert David Limited's expected FY2026 financial performance compare to its peers in the Indian pharmaceutical sector, and what growth trajectory can investors anticipate?

Given the trading window closure since April 1, 2026, what insider sentiment or institutional activity might emerge once the window reopens 48 hours after results are declared?

Will Albert David Limited maintain, increase, or discontinue its final dividend for FY2026, and how might this decision reflect the company's long-term capital allocation strategy?

Albert David Limited Submits Q4FY26 Compliance Certificate Under SEBI Depositories Regulations

1 min read     Updated on 07 Apr 2026, 01:20 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Albert David Limited filed its Q4FY26 compliance certificate under SEBI Regulation 74(5) on April 7, 2026, covering January-March 2026 period. The certificate, issued by registrar Maheshwari Datamatics Pvt. Ltd., confirms proper dematerialisation procedures and destruction of physical securities. The submission was made to NSDL, CDSL, BSE, and NSE, demonstrating the company's regulatory compliance.

powered bylight_fuzz_icon
37093827

*this image is generated using AI for illustrative purposes only.

Albert David Limited has submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Q4FY26 period, demonstrating adherence to regulatory requirements for share dematerialisation processes.

Regulatory Compliance Submission

The pharmaceutical company filed the compliance certificate under Regulation 74(5) of SEBI regulations on April 7, 2026, covering the period from January 1, 2026 to March 31, 2026. The submission was made to multiple regulatory and exchange authorities as part of mandatory quarterly reporting requirements.

Parameter: Details
Reporting Period: January 1, 2026 to March 31, 2026
Submission Date: April 7, 2026
Reference Number: SEBIDP/74(5)/Q4/2025-26
ISIN: INE155C01010

Registrar Confirmation

Maheshwari Datamatics Pvt. Ltd., serving as the company's Registrar & Share Transfer Agent, issued the compliance certificate on April 2, 2026. The registrar confirmed completion of essential dematerialisation procedures during the quarter.

The certificate validates that the registrar has:

  • Sent the Demat Transfer Register for the specified period to depositories
  • Transmitted records to all stock exchanges where Albert David shares are listed
  • Destroyed, mutilated, and cancelled all physical securities received from Depository Participants after dematerialisation within stipulated timeframes

Regulatory Recipients

The compliance certificate was submitted to key market infrastructure institutions and exchanges where the company maintains its listing and depository services.

Institution: Details
National Securities Depository Ltd.: Trade World, Lower Parel, Mumbai
Central Depository Services (India) Ltd.: Marathon Futurex, Lower Parel, Mumbai
BSE Limited: Scrip Code 524075
National Stock Exchange of India Ltd.: Symbol ALBERTDAVD

Corporate Authorization

Arun Kumar Kothari, Whole-time Director of Albert David Limited, digitally signed the submission on April 7, 2026 at 10:46:26 +05'30'. The digital signature ensures authenticity and compliance with electronic filing requirements under current regulations.

This quarterly compliance filing represents Albert David's ongoing commitment to maintaining transparency and adherence to SEBI's depositories regulations, ensuring proper handling of shareholder dematerialisation processes throughout the reporting period.

Historical Stock Returns for Albert David

1 Day5 Days1 Month6 Months1 Year5 Years
-2.07%+9.91%+19.82%-9.33%-3.09%+76.28%

How might SEBI's evolving depositories regulations impact Albert David's operational costs and compliance processes in FY27?

What trends in dematerialisation volumes could indicate changing investor sentiment toward Albert David's pharmaceutical business?

Will Albert David consider switching registrar services if digital compliance requirements become more complex in the coming quarters?

More News on Albert David

1 Year Returns:-3.09%